AbbVie Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (122)

Latest Posts

About This Stock More About This Stock
AbbVie Misses Q4 Earnings And Revenues, Shares Down
Article By: Zacks Investment Research
Friday, January 25, 2019 10:10 AM EST
AbbVie's fourth-quarter earnings came in at $1.90 per share.
In this article: ABBV
The Santa Rally Left Much To Be Desired
Article By: Lance Roberts
Saturday, December 29, 2018 4:42 PM EST
The market did finally muster a rally last week but did little to reverse any of the technical damage done over the last month. The rally was simply an oversold, short-covering, bounce that left much to be desired in terms of commitment.
In this article: GE, PFE, V, MSFT, SPY, ABBV, GDX
Don’t Be A Stock Market Victim
Article By: Chuck Carnevale
Thursday, December 20, 2018 7:35 PM EST
If you are a long-term investor, then my advice is to never let the stock market or short-term price volatility impact your investment decisions.
In this article: CVS, ABBV
November 2018 Stock Purchases
Article By: Dividend Diplomats
Friday, November 30, 2018 6:01 PM EST
After a crazy October that saw wild swings in the market and a lot of small purchases, November was calmer as many companies rebounded from that rough October.
In this article: LEG, XOM, ABBV
Stocks For You To Swing-Trade: ITW, CTXS, ABBV
Article By: Ryan Mallory
Wednesday, November 14, 2018 5:16 AM EST
Take a look at three trading ideas to prep you for the next trading session.
In this article: ITW, CTXS, ABBV


Latest Tweets for $ABBV

No tweets yet!


AbbVie Inc. Increases Humira Prices, Receives FDA Approval For New Drug
Bruce Powers 1/23/2017 6:21:09 PM

Excited to hear the #FDA approved #IMBRUVICA. Should bode very well for $ABBV. And I think it's 8% price hike of #Humira is reasonable (though I realize those taking the drug may disagree).

1 to 1 of 1 comments